Clinical and molecular evaluation of non-dominant hereditary spherocytosis.


About 75% of hereditary spherocytosis (HS) patients have the autosomal dominant form of the disease, whereas both parents of the remaining HS patients are clinically and haematologically normal. These patients could have either the autosomal recessive form of the disease or a de novo mutation. We studied 80 randomly chosen, Italian HS children with normal… (More)


Cite this paper

@article{Giudice2001ClinicalAM, title={Clinical and molecular evaluation of non-dominant hereditary spherocytosis.}, author={Emanuele Miraglia del Giudice and Bruno Nobili and Maria Teresa Francese and Luisa D'Urso and Achille Iolascon and Stephan W Eber and S. Perrotta}, journal={British journal of haematology}, year={2001}, volume={112 1}, pages={42-7} }